Colin Hislop
2014 - Anthera Pharmaceuticals
In 2014, Colin Hislop earned a total compensation of $649.5K as Chief Medical Officer at Anthera Pharmaceuticals, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $106,779 |
|---|---|
| Option Awards | $179,967 |
| Salary | $350,000 |
| Stock Awards | $12,750 |
| Total | $649,496 |
Hislop received $350K in salary, accounting for 54% of the total pay in 2014.
Hislop also received $106.8K in non-equity incentive plan, $180K in option awards and $12.8K in stock awards.
Rankings
In 2014, Colin Hislop's compensation ranked 9,356th out of 13,032 executives tracked by ExecPay. In other words, Hislop earned more than 28.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,356 out of 13,032 | 28th |
Division Manufacturing | 3,518 out of 4,966 | 29th |
Major group Chemicals And Allied Products | 1,192 out of 1,686 | 29th |
Industry group Drugs | 943 out of 1,365 | 31st |
Industry Pharmaceutical Preparations | 721 out of 1,043 | 31st |
Source: SEC filing on April 9, 2015.
Hislop's colleagues
We found six more compensation records of executives who worked with Colin Hislop at Anthera Pharmaceuticals in 2014.
2014
Paul Truex
Anthera Pharmaceuticals
Chief Executive Officer
2014
Debra Odink
Anthera Pharmaceuticals
Chief Technology Officer
2014
May Liu
Anthera Pharmaceuticals
SVP, Finance & Administration
2014
Chuck Olson
Anthera Pharmaceuticals
Chief Technology Officer
2014
Klara Dickinson
Anthera Pharmaceuticals
Senior Vice President Chief Regulatory Officer
2014
Klara Dickinson-Eason
Anthera Pharmaceuticals